Allworth Financial’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
2,781
+1,774
+176% +$4.88K ﹤0.01% 3648
2026
Q1
$1.35K Buy
1,007
+930
+1,208% +$1.85K ﹤0.01% 4476
2025
Q4
$189 Sell
77
-96
-55% -$417 ﹤0.01% 4704
2025
Q3
$1.16K Buy
173
+135
+355% +$881 ﹤0.01% 4205
2025
Q2
$224 Buy
38
+26
+217% +$169 ﹤0.01% 4300
2025
Q1
$80 Sell
12
-21
-64% -$189 ﹤0.01% 3960
2024
Q4
$312 Sell
33
-158
-83% -$1.06K ﹤0.01% 3710
2024
Q3
$1.11K Buy
191
+33
+21% +$212 ﹤0.01% 3184
2024
Q2
$1.25K Buy
+158
New +$1.28K ﹤0.01% 3094
2023
Q1
– Sell
-31
Closed -$713 – 3290
2022
Q4
$713 Buy
+31
New +$714 ﹤0.01% 2555

Other funds holding TMCI

Allworth Financial's TMCI Position: Q2 2026 in Review

Allworth Financial increased its Treace Medical Concepts (TMCI) stake by 176% in Q2 2026, buying an estimated $4.88K and bringing the position to 2,781 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

Allworth Financial first reported a position in TMCI in Q4 2022 and has held it in 10 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Allworth Financial held 2,781 shares of Treace Medical Concepts worth $11.1K as of Q2 2026.
  • Allworth Financial bought 1,774 Treace Medical Concepts shares in Q2 2026, an estimated $4.88K.
  • Treace Medical Concepts made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3648 holding.
  • Allworth Financial first reported a position in Treace Medical Concepts in Q4 2022 and has held it in 10 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.